Auto-injector that stops blood loss given funding boost

An auto-injector that can be administer at the push of a button to stop rapid blood loss has been given a £5 million funding boost by the Department of Defence.

Initially developed for use on the battlefield, it could also be adapted for any major trauma incidents, from stab wounds to road traffic accidents.

It could also be used to help women in developing countries who suffer major blood loss during birth and are unable to access medical treatment.

The TXA Autoinjector uses Tranexamic Acid, which is a cost-effective and reliable drug that stabilizes and strengthens blood clotting within damaged tissues and can be administered by an untrained user.

Currently, administration of TXA requires an intravenous drip but the development of the auto-injector will allow it to be administered safely into a muscle.

The treatment is expected to benefit up to a third of seriously injured soldiers who would otherwise die from their wounds.

Once developed, the Autoinjector could be rolled out to police, NGOs, ambulance services, and Code Red first aid kits situated in public places.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho